Related Experiment Video
Updated: Aug 8, 2026

04:30
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Stent-protected carotid angioplasty using a membrane stent: a comparative cadaver study
Stefan Müller-Hülsbeck1, Albrecht Gühne, Michael Tsokos
1Department of Radiology, University Hospital, Schleswig-Holstein-Campuskiel, Arnold-Heller-Strasse 9, 24105, Kiel, Germany. muehue@rad.uni-kiel.de
Cardiovascular and Interventional Radiology
|May 27, 2006
Summary
This study evaluated the MembraX membrane stent and Emboshield device for preventing emboli during carotid stenting. Neither showed significant advantages, though the membrane stent may reduce late embolization.
Area of Science:
- Biomedical Engineering
- Vascular Surgery
- Medical Devices
Background:
- Carotid artery stenting is a common procedure to prevent stroke.
- Embolization during stenting can lead to neurological complications.
- Novel devices aim to reduce embolic events.
Purpose of the Study:
- To assess the performance of the MembraX membrane stent in preventing acute and late embolization.
- To quantify particle embolization during carotid stent placement using human carotid explants.
- To compare the MembraX stent with a bare stent and a bare stent with an embolic protection device.
Main Methods:
- Thirty human carotid cadaveric explants were used in a pulsatile-flow model.
- Explants were randomized into three groups: MembraX stent, Xpert bare stent, and Xpert bare stent with Emboshield protection device.
- Emboli were measured in 100-micrometer filters during stent deployment, post-dilatation, and simulated late embolization.
Main Results:
- No statistically significant differences in embolic load were found between the MembraX stent and the bare stent.
- The Emboshield protection device resulted in a higher embolic load by weight and particle number compared to the bare stent.
- The MembraX stent showed a trend towards reduced particles during simulated late embolization.
Conclusions:
- Neither the MembraX membrane stent nor the Emboshield protection device demonstrated significant advantages in preventing emboli during ex vivo carotid angioplasty.
- The MembraX stent may have potential in reducing particles associated with late embolization.
- Further research is warranted to validate these findings and explore the role of embolic protection devices.
